Error: Could not add to watchlist. X
+ Watchlist

Cascadian Therapeutics Inc

3O61:GR
Frankfurt
Price not available for 3O61:GR
EUR
Volume
0
Previous Close
6.16
52Wk Range
4.84 - 18.69
Volume
0
Previous Close
6.16
52Wk Range
4.84 - 18.69
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding (m)
22.552
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.07%
% Price Change
+0.19%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Cascadian Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the development of synthetic vaccines and strategies for immunotherapy of cancer. Cascadian Therapeutics offers its services in the United States.
Address
110-110th Avenue NE, Suite 685
Bellevue, WA 98004
United States
Phone
425-450-0370
Show More